153 related articles for article (PubMed ID: 8032284)
21. Limited trafficking of a neurotropic virus through inefficient retrograde axonal transport and the type I interferon response.
Lancaster KZ; Pfeiffer JK
PLoS Pathog; 2010 Mar; 6(3):e1000791. PubMed ID: 20221252
[TBL] [Abstract][Full Text] [Related]
22. A Transgenic Mouse Model of Poliomyelitis.
Koike S; Nagata N
Methods Mol Biol; 2016; 1387():129-44. PubMed ID: 26983733
[TBL] [Abstract][Full Text] [Related]
23. Poliovirus neurovirulence and attenuation, a conceptual framework.
John TJ
Dev Biol Stand; 1993; 78():117-9. PubMed ID: 8388822
[No Abstract] [Full Text] [Related]
24. Virus-receptor interaction in poliovirus entry and pathogenesis.
Racaniello VR
Harvey Lect; 1991-1992; 87():1-16. PubMed ID: 1670545
[TBL] [Abstract][Full Text] [Related]
25. Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor.
Yang WX; Terasaki T; Shiroki K; Ohka S; Aoki J; Tanabe S; Nomura T; Terada E; Sugiyama Y; Nomoto A
Virology; 1997 Mar; 229(2):421-8. PubMed ID: 9126254
[TBL] [Abstract][Full Text] [Related]
26. Infectious cDNA, cell receptors and transgenic mice in the study of Sabin's poliovirus vaccines.
Racaniello VR
Biologicals; 1993 Dec; 21(4):365-9. PubMed ID: 8024752
[TBL] [Abstract][Full Text] [Related]
27. The molecular basis of poliovirus neurovirulence.
Ohka S; Nomoto A
Dev Biol (Basel); 2001; 105():51-8. PubMed ID: 11763337
[TBL] [Abstract][Full Text] [Related]
28. The pathogenesis of poliomyelitis: what we don't know.
Nathanson N
Adv Virus Res; 2008; 71():1-50. PubMed ID: 18585526
[TBL] [Abstract][Full Text] [Related]
29. Pathogenesis of poliovirus infection in PVRTg mice: poliovirus replicates in peritoneal macrophages.
Buisman AM; Sonsma JAJ; van Wijk MGS; Vermeulen JP; Roholl PJ; Kimman TG
J Gen Virol; 2003 Oct; 84(Pt 10):2819-2828. PubMed ID: 13679616
[TBL] [Abstract][Full Text] [Related]
30. Poliomyelitis in transgenic mice expressing CD155 under the control of the Tage4 promoter after oral and parenteral poliovirus inoculation.
Khan S; Toyoda H; Linehan M; Iwasaki A; Nomoto A; Bernhardt G; Cello J; Wimmer E
J Gen Virol; 2014 Aug; 95(Pt 8):1668-1676. PubMed ID: 24784416
[TBL] [Abstract][Full Text] [Related]
31. Retrograde transport of intact poliovirus through the axon via the fast transport system.
Ohka S; Yang WX; Terada E; Iwasaki K; Nomoto A
Virology; 1998 Oct; 250(1):67-75. PubMed ID: 9770421
[TBL] [Abstract][Full Text] [Related]
32. Poliomyelitis in intraspinally inoculated poliovirus receptor transgenic mice.
Deatly AM; Coleman JW; McMullen G; McAuliffe JM; Jayarama V; Cupo A; Crowley JC; McWilliams T; Taffs RE
Virology; 1999 Mar; 255(2):221-7. PubMed ID: 10069947
[TBL] [Abstract][Full Text] [Related]
33. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.
Abe S; Ota Y; Koike S; Kurata T; Horie H; Nomura T; Hashizume S; Nomoto A
Virology; 1995 Feb; 206(2):1075-83. PubMed ID: 7856082
[TBL] [Abstract][Full Text] [Related]
34. Tissue-specific replicating capacity of a chimeric poliovirus that carries the internal ribosome entry site of hepatitis C virus in a new mouse model transgenic for the human poliovirus receptor.
Yanagiya A; Ohka S; Hashida N; Okamura M; Taya C; Kamoshita N; Iwasaki K; Sasaki Y; Yonekawa H; Nomoto A
J Virol; 2003 Oct; 77(19):10479-87. PubMed ID: 12970433
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of injury-provoked poliomyelitis.
Gromeier M; Wimmer E
J Virol; 1998 Jun; 72(6):5056-60. PubMed ID: 9573275
[TBL] [Abstract][Full Text] [Related]
36. Expression of poliovirus receptor in human spinal cord and muscle.
Leon-Monzon ME; Illa I; Dalakas MC
Ann N Y Acad Sci; 1995 May; 753():48-57. PubMed ID: 7611659
[TBL] [Abstract][Full Text] [Related]
37. Molecular pathogenesis of type 2 poliovirus in mice.
Couderc T; Guinguene B; Horaud F; Aubert-Combiescu A; Crainic R
Eur J Epidemiol; 1989 Sep; 5(3):270-4. PubMed ID: 2551721
[TBL] [Abstract][Full Text] [Related]
38. Poliovirus and poliomyelitis: a tale of guts, brains, and an accidental event.
Mueller S; Wimmer E; Cello J
Virus Res; 2005 Aug; 111(2):175-93. PubMed ID: 15885840
[TBL] [Abstract][Full Text] [Related]
39. Characterization of mouse lines transgenic with the human poliovirus receptor gene.
Deatly AM; Taffs RE; McAuliffe JM; Nawoschik SP; Coleman JW; McMullen G; Weeks-Levy C; Johnson AJ; Racaniello VR
Microb Pathog; 1998 Jul; 25(1):43-54. PubMed ID: 9705248
[TBL] [Abstract][Full Text] [Related]
40. Inactivated poliovirus vaccine protects transgenic poliovirus receptor mice against type 3 poliovirus challenge.
Taffs RE; Chernokhvostova YV; Dragunsky EM; Nomura T; Hioki K; Beuvery EC; Fitzgerald EA; Levenbook IS; Asher DM
J Infect Dis; 1997 Feb; 175(2):441-4. PubMed ID: 9203668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
